Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions

HIV Protease

  • Antiviral Agents
    Prevalence, Mutation Patterns, and Effects on Protease Inhibitor Susceptibility of the L76V Mutation in HIV-1 Protease
    Thomas P. Young, Neil T. Parkin, Eric Stawiski, Tami Pilot-Matias, Roger Trinh, Dale J. Kempf, Michael Norton
  • Antiviral Agents
    HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance
    Soo-Yon Rhee, Jonathan Taylor, W. Jeffrey Fessel, David Kaufman, William Towner, Paolo Troia, Peter Ruane, James Hellinger, Vivian Shirvani, Andrew Zolopa, Robert W. Shafer
  • Antiviral Agents
    HIV-1 Protease Codon 36 Polymorphisms and Differential Development of Resistance to Nelfinavir, Lopinavir, and Atazanavir in Different HIV-1 Subtypes
    Irene Lisovsky, Susan M. Schader, Jorge-Luis Martinez-Cajas, Maureen Oliveira, Daniela Moisi, Mark A. Wainberg
  • Antiviral Agents
    Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations
    Rajin Shahriar, Soo-Yon Rhee, Tommy F. Liu, W. Jeffrey Fessel, Anthony Scarsella, William Towner, Susan P. Holmes, Andrew R. Zolopa, Robert W. Shafer
  • LETTERS TO THE EDITOR
    Both a Protective and a Deleterious Role for the L76V Mutation
    Alessandra Tartaglia, Annalisa Saracino, Laura Monno, Carmine Tinelli, Gioacchino Angarano
  • Antiviral Agents
    Genotypic Resistance Analysis of the Virological Response to Fosamprenavir-Ritonavir in Protease Inhibitor-Experienced Patients in CONTEXT and TRIAD Clinical Trials
    Anne-Geneviève Marcelin, Philippe Flandre, Jean-Michel Molina, Christine Katlama, Patrick Yeni, Francois Raffi, Zeina Antoun, Mounir Ait-Khaled, Vincent Calvez
  • Antiviral Agents
    Tipranavir-Ritonavir Genotypic Resistance Score in Protease Inhibitor-Experienced Patients
    Anne-Genevieve Marcelin, Bernard Masquelier, Diane Descamps, Jacques Izopet, Charlotte Charpentier, Chakib Alloui, Magali Bouvier-Alias, Anne Signori-Schmuck, Brigitte Montes, Marie-Laure Chaix, Corinne Amiel, Georges Dos Santos, Annick Ruffault, Francis Barin, Gilles Peytavin, Marc Lavignon, Philippe Flandre, Vincent Calvez
  • Antiviral Agents
    Tipranavir (TPV) Genotypic Inhibitory Quotient Predicts Virological Response at 48 Weeks to TPV-Based Salvage Regimens
    Daniel Gonzalez de Requena, Stefano Bonora, Andrea Calcagno, Antonio D'Avolio, Marco Siccardi, Silvia Fontana, Maria Grazia Milia, Mauro Sciandra, Silvia Garazzino, Antonio Di Garbo, Lorena Baietto, Laura Trentini, Giovanni Di Perri
  • AUTHOR'S CORRECTION
    Predictive Genotypic Algorithm for Virologic Response to Lopinavir-Ritonavir in Protease Inhibitor-Experienced Patients
    Martin S. King, Richard Rode, Isabelle Cohen-Codar, Vincent Calvez, Anne-Geneviève Marcelin, George J. Hanna, Dale J. Kempf
  • Antiviral Agents
    Factors Associated with the Selection of Mutations Conferring Resistance to Protease Inhibitors (PIs) in PI-Experienced Patients Displaying Treatment Failure on Darunavir
    Sidonie Lambert-Niclot, Philippe Flandre, Ana Canestri, Gilles Peytavin, Christine Blanc, Rachid Agher, Cathia Soulié, Marc Wirden, Christine Katlama, Vincent Calvez, Anne-Geneviève Marcelin

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
Back to top

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596